Interferon lambda signals in maternal tissues to exert protective and pathologic effects in a gestational-stage dependent manner

Interferon lambda (IFN-{lambda}, type III IFN) is constitutively secreted from human placental cells in culture and reduces Zika virus (ZIKV) transplacental transmission in mice. However, the roles of IFN-{lambda} during healthy pregnancy and in restricting congenital infection remain unclear. Here we used mice lacking the IFN-{lambda} receptor (Ifnlr1-/-) to generate pregnancies lacking either maternal or fetal IFN-{lambda} responsiveness and found that the antiviral effect of IFN-{lambda} resulted from signaling exclusively in maternal tissues. This protective effect depended on gestational stage, as infection earlier in pregnancy (E7 rather than E9) resulted in enhanced transplacental transmission of ZIKV. In Ifnar1-/- dams, which sustain robust ZIKV infection, maternal IFN-{lambda} signaling caused fetal resorption and intrauterine growth restriction. Pregnancy pathology elicited by poly(I:C) treatment also was mediated by maternal IFN-{lambda} signaling, specifically in maternal leukocytes, and also occurred in a gestational stage-dependent manner. These findings identify an unexpected effect of IFN-{lambda} signaling specifically in maternal (rather than placental or fetal) tissues, which is distinct from the pathogenic effects of IFN-{beta} (type I IFN) during pregnancy. These results highlight the complexity of immune signaling at the maternal-fetal interface, where disparate outcomes can result from signaling at different gestational stages. IMPORTANCEPregnancy is an immunologically complex situation, which must balance protecting the fetus from maternal pathogens with preventing maternal immune rejection of non-self fetal and placental tissue. Cytokines, such as interferon lambda (IFN-{lambda}), contribute to antiviral immunity at the maternal-fetal interface. We found in a mouse model of congenital Zika virus infection that IFN-{lambda} can have either a protective antiviral effect or cause immune-mediated pathology, depending on the stage of gestation when IFN-{lambda} signaling occurs. Remarkably, both the protective and pathologic effects of IFN-{lambda} occurred through signaling exclusively in maternal immune cells, rather than in fetal or placental tissues, or in other maternal cell types, identifying a new role for IFN-{lambda} at the maternal-fetal interface.